Home › Employers › Quanta Therapeutics, Inc.
Quanta Therapeutics, Inc.: H-1B salaries and sponsorship
Quanta Therapeutics, Inc. filed 4 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 4. Median offered salary: $119,393.
Does Quanta Therapeutics, Inc. sponsor H-1B visas?
Quanta Therapeutics, Inc. filed 4 labor condition applications in fiscal years 2023–2026, the latest submitted on Jun 5, 2025. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Senior Research Associate | 3 | $123,786 |
| Research Scientist | 1 | $115,000 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2024 | 2 | $112,500 |
| FY2025 | 2 | $123,786 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Senior Research Associate | $123,786 Level II | South San Francisco, CA | Jun 5, 2025 | Oct 1, 2025 | Certified |
| Senior Research Associate | $123,786 Level II | San Francisco, CA | Apr 25, 2025 | Oct 1, 2025 | Certified, then withdrawn |
| Senior Research Associate | $110,000 Level II | Radnor, PA | Feb 29, 2024 | Mar 25, 2024 | Certified |
| Research Scientist | $115,000 Level I | South San Francisco, CA | Feb 28, 2024 | Mar 18, 2024 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).